Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.1K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

2.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.0K
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

303
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
303
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

490
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
490
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

286
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
286
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Somatic Genetic Rescue of Immunodeficiency in WHIM Syndrome.

The New England journal of medicine·2026
Same author

Prime Editing for p47<sup>phox</sup>-Deficient Chronic Granulomatous Disease.

The New England journal of medicine·2025
Same author

Reliable genetic diagnosis of <i>NCF1</i> (p47<sup>phox</sup>)-deficient chronic granulomatous disease using high-throughput sequencing.

Frontiers in immunology·2025
Same author

Neutralizing GM-CSF autoantibodies impair neutrophil antifungal effector function in a patient with aspergillosis.

The Journal of infection·2025
Same author

Immunopathological and microbial signatures of inflammatory bowel disease in partial RAG deficiency.

The Journal of experimental medicine·2025
Same author

Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection.

JCI insight·2025

Related Experiment Video

Updated: Jan 23, 2026

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
06:22

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Published on: September 19, 2025

447

Diagnostic Testing for Chronic Granulomatous Disease.

Douglas B Kuhns1

  • 1Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA. dkuhns@mail.nih.gov.

Methods in Molecular Biology (Clifton, N.J.)
|June 8, 2019
PubMed
Summary

Chronic granulomatous disease (CGD) diagnosis relies on assessing neutrophil reactive oxygen species (ROS) production. Combining multiple ROS assays and protein defect identification provides comprehensive diagnostic and prognostic information for CGD patients.

Keywords:
Chronic granulomatous diseaseNOX2Phox proteinsROS production

More Related Videos

Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics
07:42

Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics

Published on: February 19, 2017

9.2K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.7K

Related Experiment Videos

Last Updated: Jan 23, 2026

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections
06:22

Machine Learning-Based Cough Tone Classification: Diagnostic Exploration of Chronic Obstructive Pulmonary Disease and Respiratory Tract Infections

Published on: September 19, 2025

447
Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics
07:42

Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics

Published on: February 19, 2017

9.2K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.7K

Area of Science:

  • Immunology
  • Genetics

Background:

  • Chronic granulomatous disease (CGD) is a rare primary immunodeficiency.
  • CGD impairs phagocyte ability to produce reactive oxygen species (ROS), crucial for fighting infections.
  • Recurrent infections, granulomas, and increased mortality are hallmarks of CGD.

Purpose of the Study:

  • To review diagnostic assays for CGD, focusing on ROS production and protein defects.
  • To emphasize the importance of using multiple assays for accurate diagnosis and prognosis.
  • To outline a comprehensive diagnostic strategy for CGD patients.

Main Methods:

  • Flow cytometric dihydrorhodamine (DHR) assay.
  • Histochemical nitroblue tetrazedale (NBT) assay.
  • Quantitative assays: O2•− reduction of ferricytochrome c and luminol-enhanced chemiluminescence.
  • Protein defect identification: immunoblotting and flow cytometry with phox-specific antibodies.

Main Results:

  • Multiple assays can assess ROS production in individual cells or cell populations.
  • Specific methods exist to identify the defective phagocyte oxidase (phox) protein.
  • Assay results should be consistent to confirm diagnosis and guide treatment.

Conclusions:

  • A combination of ROS production and protein defect assays is essential for CGD diagnosis.
  • Comprehensive testing aids in genetic sequencing and patient prognosis.
  • Standardized diagnostic approaches improve patient management for CGD.